{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:51:18Z","timestamp":1787698278871,"version":"build-2784847793"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute of Health and Social Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001279","name":"Great Ormond Street Hospital Children\u2019s Charity Livingstone Skin Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001282","name":"UCL Great Ormond Street Institute of Child Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001282","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Segmental macular hyperpigmentation (SMH) is macular hyperpigmentation in a defined developmental pattern, presenting at birth or in the early years. The only known cause of this phenotype has been mosaicism of gene GNAS, as part of McCune\u2013Albright syndrome. It is unknown how often GNAS mosaicism is the cause of SMH presenting to dermatology or whether there are other genetic causes for the phenotype with different clinical implications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To investigate the genetic causes of SMH and the natural history of the condition.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A prospective cohort of 50 children were recruited consecutively for phenotypic and genotypic studies over a period of 15\u2005years. High-depth next-generation sequencing of affected skin with bioinformatic analysis optimized for mosaic variant detection was performed in 42 children.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Three patients with mosaic GNAS variants were identified, all otherwise well at presentation, but one of whom went on to develop endocrine complications in the follow-up period. Importantly, in a further five patients, new genetic causes were identified. These were pathogenic mosaic variants in single genes (NRAS, n = 2; BRAF, n = 1; PTPN11, n = 1) and a mosaic chromosomal copy number variant (chromosome 5p gain, n = 1), all undetectable in blood. In most cases, the variant allele frequency was extremely low, probably reflecting the very few variant cells in a whole skin biopsy of a macular lesion, and it is possible that causative variants in tested genes are still being missed, even at current sensitivities.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The discovery of these highly disparate genetic causes has important implications for personalized patient management. Specifically, detection of GNAS variants will involve monitoring and investigation of other systems; NRAS\/BRAF\/PTPN11 will involve discussion of melanoma awareness and the potential of passing on variants as germline diseases to future offspring; and chromosomal abnormalities may have implications in multiple clinical areas. Our findings multiply the known causes of SMH and reveal the importance of genotyping patients presenting to dermatology, even when clinically well.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bjd\/ljaf254","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T16:47:36Z","timestamp":1752252456000},"page":"987-995","source":"Crossref","is-referenced-by-count":5,"title":["Segmental macular hyperpigmentation: new genes, new clinical implications"],"prefix":"10.1093","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6256-327X","authenticated-orcid":false,"given":"Veronica A","family":"Kinsler","sequence":"first","affiliation":[{"name":"NHS England Rare Disease Collaborative Network for Mosaic Disorders, Paediatric Dermatology, Great Ormond Street Hospital for Children , London ,","place":["UK"]},{"name":"Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health , London ,","place":["UK"]},{"name":"Mosaicism and Precision Medicine Laboratory, The Francis Crick Institute , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6438-6550","authenticated-orcid":false,"given":"Nicole","family":"Kn\u00f6pfel","sequence":"additional","affiliation":[{"name":"NHS England Rare Disease Collaborative Network for Mosaic Disorders, Paediatric Dermatology, Great Ormond Street Hospital for Children , London ,","place":["UK"]},{"name":"Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health , London ,","place":["UK"]},{"name":"Mosaicism and Precision Medicine Laboratory, The Francis Crick Institute , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7195-5670","authenticated-orcid":false,"given":"Satyamaanasa","family":"Polubothu","sequence":"additional","affiliation":[{"name":"NHS England Rare Disease Collaborative Network for Mosaic Disorders, Paediatric Dermatology, Great Ormond Street Hospital for Children , London ,","place":["UK"]},{"name":"Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"key":"2025101708271959200_ljaf254-B1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/pcmr.12645","article-title":"The patterns of birthmarks suggest a novel population of melanocyte precursors arising around the time of gastrulation","volume":"31","author":"Kinsler","year":"2018","journal-title":"Pigment Cell Melanoma Res"},{"key":"2025101708271959200_ljaf254-B2","author":"Kinsler"},{"key":"2025101708271959200_ljaf254-B3","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/j.1365-2133.2010.09702.x","article-title":"Segmental pigmentation disorder","volume":"162","author":"Hogeling","year":"2010","journal-title":"Br J Dermatol"},{"key":"2025101708271959200_ljaf254-B4","first-page":"adv00707","article-title":"Segmental pigmentation disorder: clinical manifestations and epidemiological features in 144 patients, a retrospective case\u2013control study","volume":"102","author":"Oren-Shabtai","year":"2022","journal-title":"Acta Dermatovenereol"},{"key":"2025101708271959200_ljaf254-B5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/pde.15276","article-title":"Low rates of neurological abnormalities in patients with pigmentary mosaicism: a retrospective cohort study from a tertiary dermatology center","volume":"40","author":"Pagani","year":"2023","journal-title":"Pediatr Dermatol"},{"key":"2025101708271959200_ljaf254-B6","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM199112123252403","article-title":"Activating mutations of the stimulatory G protein in the McCune\u2013Albright syndrome","volume":"325","author":"Weinstein","year":"1991","journal-title":"N Engl J Med"},{"key":"2025101708271959200_ljaf254-B7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jpeds.2004.05.025","article-title":"Activating GNAS1 gene mutations in patients with premature thelarche","volume":"145","author":"Roman","year":"2004","journal-title":"J Pediatr"},{"key":"2025101708271959200_ljaf254-B8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3390\/genes15010120","article-title":"Choosing the best tissue and technique to detect mosaicism in fibrous dysplasia\/McCune\u2013Albright syndrome (FD\/MAS)","volume":"15","author":"Vado","year":"2024","journal-title":"Genes (Basel)"},{"key":"2025101708271959200_ljaf254-B9","doi-asserted-by":"crossref","first-page":"1377716","DOI":"10.3389\/fgene.2024.1377716","article-title":"The prevalence, diagnostic accuracy and genotype-phenotype correlation of GNAS mutations in fibrous dysplasia: a meta-analysis","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Genet"},{"key":"2025101708271959200_ljaf254-B10","author":"Szymczuk"},{"key":"2025101708271959200_ljaf254-B11","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/bjd.17924","article-title":"Mosaic abnormalities of the skin: review and guidelines from the European Reference Network for rare skin diseases","volume":"182","author":"Kinsler","year":"2020","journal-title":"Br J Dermatol"},{"key":"2025101708271959200_ljaf254-B12","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/gim.2016.220","article-title":"Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommendations for genetic testing","volume":"19","author":"Kuentz","year":"2017","journal-title":"Genet Med"},{"issue":"Suppl. 1","key":"2025101708271959200_ljaf254-B13","first-page":"C29.1","article-title":"Provision of a diagnostic service for mosaic skin disorders; experience from the first 500 cases including novel variants and mutational hot-spots","volume":"32","author":"Cullup","year":"2024","journal-title":"Eur J Hum Genet"},{"key":"2025101708271959200_ljaf254-B14","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1172\/JCI98589","article-title":"Mosaic RAS\/MAPK variants cause sporadic vascular malformations which respond to targeted therapy","volume":"128","author":"Al-Olabi","year":"2018","journal-title":"J Clin Invest"},{"key":"2025101708271959200_ljaf254-B15","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation","volume":"23","author":"Legius","year":"2021","journal-title":"Genet Med"},{"key":"2025101708271959200_ljaf254-B16","doi-asserted-by":"publisher","author":"Kinsler","DOI":"10.1093\/bjd\/ljaf224"},{"key":"2025101708271959200_ljaf254-B17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1089\/thy.1997.7.433","article-title":"Hyperthyroidism in McCune\u2013Albright syndrome with a review of thyroid abnormalities sixty years after the first report","volume":"7","author":"Mastorakos","year":"1997","journal-title":"Thyroid"},{"key":"2025101708271959200_ljaf254-B18","first-page":"P470","article-title":"McCune\u2013Albright syndrome diagnosed in adulthood with GNAS mutation-related hyperthyroidism and elevated anti-TPO antibodies","volume":"81","author":"Zajickova","year":"2022","journal-title":"Endocrine Abstracts"},{"key":"2025101708271959200_ljaf254-B19","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jid.2019.10.019","article-title":"GNA11 mutation as a cause of Sturge\u2013Weber syndrome: expansion of the phenotypic spectrum of Galpha\/11 mosaicism and the associated clinical diagnoses","volume":"140","author":"Polubothu","year":"2020","journal-title":"J Invest Dermatol"},{"key":"2025101708271959200_ljaf254-B20","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.jid.2019.08.455","article-title":"Reverse phenotyping in patients with skin capillary malformations and mosaic GNAQ or GNA11 mutations defines a clinical spectrum with genotype\u2013phenotype correlation","volume":"140","author":"Jordan","year":"2020","journal-title":"J Invest Dermatol"},{"key":"2025101708271959200_ljaf254-B21","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jaad.2024.09.085","article-title":"Becker naevi are associated with neurologic abnormalities","volume":"92","author":"Lopez-Balboa","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"2025101708271959200_ljaf254-B22","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jid.2022.09.661","article-title":"PTPN11 mosaicism causes a spectrum of pigmentary and vascular neurocutaneous disorders and predisposes to melanoma","volume":"143","author":"Polubothu","year":"2023","journal-title":"J Invest Dermatol"},{"key":"2025101708271959200_ljaf254-B23","doi-asserted-by":"crossref","first-page":"D805","DOI":"10.1093\/nar\/gku1075","article-title":"COSMIC: exploring the world's knowledge of somatic mutations in human cancer","volume":"43","author":"Forbes","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2025101708271959200_ljaf254-B24","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/ejhg.2017.65","article-title":"Genotype and phenotype spectrum of NRAS germline variants","volume":"25","author":"Altmuller","year":"2017","journal-title":"Eur J Hum Genet"},{"key":"2025101708271959200_ljaf254-B25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00401-012-0945-0","article-title":"Neuropathology of neurocutaneous melanosis: histological foci of melanotic neurones and glia may be undetectable on MRI","volume":"123","author":"Kinsler","year":"2012","journal-title":"Acta Neuropathol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljaf254\/63729822\/ljaf254.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/193\/5\/987\/63729822\/ljaf254.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/193\/5\/987\/63729822\/ljaf254.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T12:27:32Z","timestamp":1760704052000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/193\/5\/987\/8196805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,7,11]]},"published-print":{"date-parts":[[2025,10,17]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljaf254","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,7,11]]}}}